Idiopathic dilated cardiomyopathy in an Omani population of the Arabian Peninsula

Prevalence, clinical profile and natural history

A. K. Agarwal, P. Venugopalan, A. K. Meharali, D. De Debono

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

We have analysed prospectively the prevalence and clinical profile of idiopathic dilated cardiomyopathy (IDC) in a circumscribed native population of the Sultanate of Oman over 3 years (1992-1994). Identified patients were followed up for a period ranging from 1 to 8 years (median 4 years) and the variables related to outcome determined. IDC was diagnosed in 97 patients, giving a prevalence of 43.2/100,000 population during the study period. 84.5% of patients were aged over 35 years and males outnumbered females (M/F = 1.4:1). Factors related to poor outcome were an initial left ventricular ejection fraction ≤30% (P = 0.01), severe symptoms, i.e. NYHA functional class III or IV at presentation (P = 0.04), and significant ventricular tachycardia during follow up (P = 0.02). However, multivariate regression analysis yielded only low LVEF as the predictor of poor outcome (P = 0.01). When analysed from age of onset of symptoms, survival figures were 94% at 1 year (95% CI 88 to 99%), 76% at 5 years (95% CI 67 to 86%) and 68% at 8 years (95% CI 54 to 82%). Mean survival was 6.5 years (95% CI 6 to 7 years). Patients were still at risk of fatal ventricular arrhythmia even when haemodynamically stable and had left ventricular ejection fraction >30%. (C) 2000 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)147-158
Number of pages12
JournalInternational Journal of Cardiology
Volume75
Issue number2-3
DOIs
Publication statusPublished - Sep 15 2000

Fingerprint

Dilated Cardiomyopathy
Natural History
Stroke Volume
Population
Oman
Survival
Ventricular Tachycardia
Age of Onset
Cardiac Arrhythmias
Multivariate Analysis
Regression Analysis

Keywords

  • Epidemiology
  • Idiopathic dilated cardiomyopathy
  • Middle East
  • Outcome variables
  • Survival

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Idiopathic dilated cardiomyopathy in an Omani population of the Arabian Peninsula : Prevalence, clinical profile and natural history. / Agarwal, A. K.; Venugopalan, P.; Meharali, A. K.; De Debono, D.

In: International Journal of Cardiology, Vol. 75, No. 2-3, 15.09.2000, p. 147-158.

Research output: Contribution to journalArticle

@article{01a2093a117d4148901dd52da1c4a107,
title = "Idiopathic dilated cardiomyopathy in an Omani population of the Arabian Peninsula: Prevalence, clinical profile and natural history",
abstract = "We have analysed prospectively the prevalence and clinical profile of idiopathic dilated cardiomyopathy (IDC) in a circumscribed native population of the Sultanate of Oman over 3 years (1992-1994). Identified patients were followed up for a period ranging from 1 to 8 years (median 4 years) and the variables related to outcome determined. IDC was diagnosed in 97 patients, giving a prevalence of 43.2/100,000 population during the study period. 84.5{\%} of patients were aged over 35 years and males outnumbered females (M/F = 1.4:1). Factors related to poor outcome were an initial left ventricular ejection fraction ≤30{\%} (P = 0.01), severe symptoms, i.e. NYHA functional class III or IV at presentation (P = 0.04), and significant ventricular tachycardia during follow up (P = 0.02). However, multivariate regression analysis yielded only low LVEF as the predictor of poor outcome (P = 0.01). When analysed from age of onset of symptoms, survival figures were 94{\%} at 1 year (95{\%} CI 88 to 99{\%}), 76{\%} at 5 years (95{\%} CI 67 to 86{\%}) and 68{\%} at 8 years (95{\%} CI 54 to 82{\%}). Mean survival was 6.5 years (95{\%} CI 6 to 7 years). Patients were still at risk of fatal ventricular arrhythmia even when haemodynamically stable and had left ventricular ejection fraction >30{\%}. (C) 2000 Elsevier Science Ireland Ltd.",
keywords = "Epidemiology, Idiopathic dilated cardiomyopathy, Middle East, Outcome variables, Survival",
author = "Agarwal, {A. K.} and P. Venugopalan and Meharali, {A. K.} and {De Debono}, D.",
year = "2000",
month = "9",
day = "15",
doi = "10.1016/S0167-5273(00)00315-6",
language = "English",
volume = "75",
pages = "147--158",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2-3",

}

TY - JOUR

T1 - Idiopathic dilated cardiomyopathy in an Omani population of the Arabian Peninsula

T2 - Prevalence, clinical profile and natural history

AU - Agarwal, A. K.

AU - Venugopalan, P.

AU - Meharali, A. K.

AU - De Debono, D.

PY - 2000/9/15

Y1 - 2000/9/15

N2 - We have analysed prospectively the prevalence and clinical profile of idiopathic dilated cardiomyopathy (IDC) in a circumscribed native population of the Sultanate of Oman over 3 years (1992-1994). Identified patients were followed up for a period ranging from 1 to 8 years (median 4 years) and the variables related to outcome determined. IDC was diagnosed in 97 patients, giving a prevalence of 43.2/100,000 population during the study period. 84.5% of patients were aged over 35 years and males outnumbered females (M/F = 1.4:1). Factors related to poor outcome were an initial left ventricular ejection fraction ≤30% (P = 0.01), severe symptoms, i.e. NYHA functional class III or IV at presentation (P = 0.04), and significant ventricular tachycardia during follow up (P = 0.02). However, multivariate regression analysis yielded only low LVEF as the predictor of poor outcome (P = 0.01). When analysed from age of onset of symptoms, survival figures were 94% at 1 year (95% CI 88 to 99%), 76% at 5 years (95% CI 67 to 86%) and 68% at 8 years (95% CI 54 to 82%). Mean survival was 6.5 years (95% CI 6 to 7 years). Patients were still at risk of fatal ventricular arrhythmia even when haemodynamically stable and had left ventricular ejection fraction >30%. (C) 2000 Elsevier Science Ireland Ltd.

AB - We have analysed prospectively the prevalence and clinical profile of idiopathic dilated cardiomyopathy (IDC) in a circumscribed native population of the Sultanate of Oman over 3 years (1992-1994). Identified patients were followed up for a period ranging from 1 to 8 years (median 4 years) and the variables related to outcome determined. IDC was diagnosed in 97 patients, giving a prevalence of 43.2/100,000 population during the study period. 84.5% of patients were aged over 35 years and males outnumbered females (M/F = 1.4:1). Factors related to poor outcome were an initial left ventricular ejection fraction ≤30% (P = 0.01), severe symptoms, i.e. NYHA functional class III or IV at presentation (P = 0.04), and significant ventricular tachycardia during follow up (P = 0.02). However, multivariate regression analysis yielded only low LVEF as the predictor of poor outcome (P = 0.01). When analysed from age of onset of symptoms, survival figures were 94% at 1 year (95% CI 88 to 99%), 76% at 5 years (95% CI 67 to 86%) and 68% at 8 years (95% CI 54 to 82%). Mean survival was 6.5 years (95% CI 6 to 7 years). Patients were still at risk of fatal ventricular arrhythmia even when haemodynamically stable and had left ventricular ejection fraction >30%. (C) 2000 Elsevier Science Ireland Ltd.

KW - Epidemiology

KW - Idiopathic dilated cardiomyopathy

KW - Middle East

KW - Outcome variables

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=0034664894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034664894&partnerID=8YFLogxK

U2 - 10.1016/S0167-5273(00)00315-6

DO - 10.1016/S0167-5273(00)00315-6

M3 - Article

VL - 75

SP - 147

EP - 158

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 2-3

ER -